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Type I PIPkinases Interact with and Are Regulated
by the Retinoblastoma Susceptibility
Gene Product—pRB
PtdIns(4,5)P2 and the products of its hydrolysis in the
regulation of cell cycle progression [7, 8, 15–17].
Cellular PtdIns(4,5)P2 is synthesized by two distinct
families of PIPkinases (Type I and Type II PIPkinase),
each of which are composed of three isoforms [1, 18],
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121 Plesmanlaan and members of both families have been shown to be
present in nuclei [19, 20]. Our data have suggested thatAmsterdam 1066CX
The Netherlands the major pathway of nuclear PtdIns(4,5)P2 synthesis
occurs through a Type I PIPkinase, which phosphory-2 Wellcome/CRC Institute and Department
of Pathology lates PtdIns(4)P on the 5 position of the inositol ring
(unpublished data and [21]). Furthermore, we showedUniversity of Cambridge
Cambridge CB2 1QR that PtdIns(4,5)P2 synthesis is stimulated as cells prog-
ress from G1 to S phase of the cell cycle [11]. TheUnited Kingdom
mechanism by which cell cycle progression impinges
on nuclear inositide synthesis is not known.
As pRB is a regulator of entry into S phase and nuclear
Summary PtdIns(4,5)P2 synthesis dramatically increases during
this phase [11], we assessed if any lipid kinases were
Inositide signaling at the plasma membrane has been able to interact with pRB. Cell lysates were prepared
implicated in the regulation of numerous cellular pro- either from MEL cells or from rat brain tissue, incubated
cesses including cytoskeletal dynamics, vesicle traf- with a number of GST proteins and then assayed for
ficking [1], and gene transcription [2]. Studies have associated lipid kinase activity. Mixed lipid vesicles con-
also shown that a distinct inositide pathway exists in taining PtdIns (to detect PtdIns-kinase activity), PtdInsP
nuclei [3], where it may regulate nuclear processes (a mixture of PtdIns(4)P, PtdIns(5)P, and PtdIns(3)P to
such as mRNA export [4], cell cycle progression [5–8], detect PIPkinase activity), and PtdIns(4,5)P2 (to detect
gene transcription [9], and DNA repair [10]. We pre- PtdIns(4,5)P2-3-kinase) were used to assess associated
viously demonstrated that nuclear PtdIns(4,5)P2 syn- activities. Niether PtdIns-kinase nor PtdIns(4,5)P2-3-
thesis is stimulated during progression from G1 kinase activity was detected in the GST-pRB-affinity
through S phase [11], although mechanistic details of purifications from either rat brain or from MEL cell ly-
how cell cycle progression impinges on the regulation sates. In contrast, 50-fold more PIPkinase activity was
of nuclear inositides is unknown. In this study, we associated with GST-pRB beads compared to GST
demonstrate that pRB, which regulates progression alone (Figure 1). This activity bound to both the small
of cells from G1 through S phase [12] interacts both pocket domain (GST-pRB(379–792)) as well as to the
in vitro and in vivo with Type I PIPkinases, the enzymes longer form (GST-pRB(379–917)) of pRB, which includes
responsible for nuclear PtdIns(4,5)P2 synthesis. More- the C terminus (Figure 1). To determine which family
over, this interaction stimulates the activity of Type I of PIPkinase (either Type I or Type II PIPkinase) was
PIPkinase in an in vitro assay. Using murine erythroleu- responsible for this activity, the labeled PtdIns(4,5)P2
kamia (MEL) cells expressing a temperature-sensitive was degraded using a specific PtdIns(4,5)P2-5-phos-
mutant of large T antigen (LTA), we demonstrate phatase. Most of the label was found as released phos-
changes in vivo in nuclear PtdIns(4,5)P2 levels that are phate, suggesting that a Type I PIPkinase accounted
consistent with the ability of LTA to disrupt pRB/Type for the majority of the GST-pRB-associated PIPkinase
I interactions. This study, for the first time, provides a activity (data not shown). A similar conclusion was
potential mechanism for how cell cycle progression drawn using specific substrates (either PtdIns(4)P or
could regulate the levels of nuclear inositides. PtdIns(5)P) for the two different families of enzymes
(data not shown). No synthesis of 3-phosphorylated lip-
ids was detected in the pRB-interacting fractions.Results and Discussion
To determine which isoforms of Type I PIPkinases
associate with pRB, we expressed the three known iso-Nuclear inositides and the enzymes that synthesize
forms in Cos-7 cells and tested these lysates for interac-them are distinctly regulated from their plasma mem-
tion with GST-pRB(379–729) or GST alone. All three iso-brane counterparts [3, 13] and appear to have disparate
forms of Type I PIPkinase (, , and ) interactedfunctions. For example, overexpression of an inositide-
specifically with GST-pRB(379–729), and the Type Ispecific phospholipase (PIC) within the nuclear com-
showed the highest binding under the conditions usedpartment leads to enhanced progression through the
(Figure 2A). Specificity was demonstrated by the ab-cell cycle, while the overexpression of an active mutant
sence of any interaction between Type I PIPkinases andunable to enter the nucleus has no effect [14]. Moreover,
GST or between GST-pRB and myc-PIC1 (Figure 2A),a number of studies have pointed to a role for nuclear
another nuclear phosphoinositide-metabolizing enzyme.
To determine which region is involved in binding to pRB,
nonoverlapping deletions were created in the Type I3 Correspondence: ndivecha@nki.nl
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Figure 1. PIPkinase Activity Associates with
the Retinoblastoma Protein, pRB
The denoted GST proteins were incubated
with either rat brain or MEL cell lysates for
1 hr, washed, and assayed for various lipid
kinase activities. The labeled lipids were sep-
arated using TLC, and the incorporation of
radioactivity was visualized using a phos-
phorimager. Both GST-pRB(379–917) and
GST-pRB(379–792) bound more than 20
times the amount of PIPkinase activity com-
pared to either GST alone or the GST-E2F
or GST-Type II PIPkinase. Quantification of
PIPkinase activities after separation of the lip-
ids on TLC is depicted graphically. The data
are from a single experiment, which is repre-
sentative of three.
PIPkinase. These data showed that the pocket domain cyclin E/A [12]. Therefore, we tested whether PIPkinases
could modulate pRB-mediated repression of an E2F-of pRB interacts with the N terminus of Type I PIPki-
nase, between residues 22 and 108 (Figure 2B). This driven promoter. U2OS or C33A cells were transfected
with an E2F-sensitive promoter coupled to the luciferaseregion is highly conserved in all three Type I PIPkinases,
providing a rational explanation for the observed bind- gene together with E2F in the absence or the presence
of pRB. Expression of E2F led to a 15-fold activation ofing. No LxCxE motif, previously characterized as a pRB
pocket domain binding site, is present in Type I PIPki- luciferase activity, which was subsequently inhibited by
30% by the cotransfection of 0.1 g pRB (transfectionnases, suggesting the presence of a novel interaction
domain. of 1 g was able to completely inhibit transcription from
this promoter). No significant inhibition or activationThe small pocket domain (encoded by amino acid
residues 379–792) of pRB constitutes the smallest re- could be seen by cotransfection of Type I PIPkinases
(data not shown).pressor motif and is made up of two highly conserved
sequences termed A and B [22], which interact to form As Type I PIPkinases do not affect pRB/E2F-mediated
transcription, we tested if pRB could affect Type I PIPki-a functional E2F repressor. A number of naturally oc-
curring mutations have been characterized that lead to nase activity. Type I PIPkinase was expressed and
purified from Cos-7 cells. The pocket domain ofthe disruption of the pocket domain and inactivation of
pRB function. Interestingly, while all three isoforms of pRB(379–729) was expressed and purified from bacte-
ria, and the GST portion was cleaved using thrombin.PIPkinase were able to interact with GST-pRB(379–917),
this was dramatically diminished with a naturally oc- Type I PIPkinase, pRB, or GST were combined on ice
with vesicles containing PtdOH and PtdInsP, and com-curring pRB pocket domain mutant in which exon
22(22) was deleted (Figure 2C). plexes were allowed to form before being assayed for
Type I PIPkinase activity. The addition of pRB led to aFinally, we assessed the interaction between Type
I PIPkinases and pRB in vivo. Immunoprecipitation of 4-fold increase in Type I PIPkinase activity (Figure 3).
These effects were specific, as the addition of GST aloneendogenous Type I PIPkinase from MEL cell lysates,
using a mix of anti-Type I PIPkinase antibodies [23], had no effect and boiling the pRB reduced this activation
(Figure 3). These data suggest that the Type IPIPkinaseled to the coimmunoprecipitation of endogenous pRB
(Figure 2D, lane 2), as detected by Western blotting is a direct target for regulation by pRB.
To assess the potential role of pRB-mediated Type Iusing a specific anti-pRB antibody. No such band was
detected if the anti-Type I PIPkinase antibodies were PIPkinase activation in vivo, we sought to use large T
antigen expression to inhibit pRB function. Preincuba-used in a mock immunoprecipitiation in which the MEL
cell lysate was replaced with lysis buffer alone (Figure tion of GST-pRB(379–917) with an excess of Cos cell
lysates, which express large T antigen (LTA), blocked2D, lane 4). Specificity of the interaction was also dem-
onstrated by the absence of pRB in immunoprecipitates the subsequent interaction of GST-RB with the Type
I PIPkinase (Figure 4A). Although, other pRB bindingfrom MEL cell lysates using a preimmune serum (Figure
2D, lane 1). proteins are likely to be present in Cos cell lysates, the
major one is likely to be LTA. This is demonstrated bypRb regulates the transition from G1 into S phase of
the cell cycle through transcriptional control of genes, the dramatic increase in LTA associated with GST-
pRB(379–917) after preincubation with Cos cell lysatessuch as thymidine-kinase, dihydrofolate reductase, and
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Figure 2. All Three Isoforms of Type I PIPkinase Interact with pRB
(A) Myc-tagged Type I PIPkinase isoforms were expressed in Cos-7 cells and were used for affinity purification with either GST or GST-
pRB(379–792). The associated proteins bound to the GST constructs were separated by SDS-PAGE and visualized after blotting with an anti-
myc antibody. The left panel represents the total lysates, while the right panel shows a blot of the proteins associated with either GST or
GST-pRB(379–792); lane 1: PIC1, lane 2: Type I PIPkinase, lane 3: Type I PIPkinase, and lane 4: Type I PIPkinase.
(B) Type I PIPkinase deletions were expressed in Cos-7 cells and were used for affinity purification using either GST (lanes 1 and 3) or GST-
pRB(379–792) (lane 2 and 4). Lanes 1 and 2 were incubated with a Type I PIPkinase deletion containing only the first 107 residues. Lanes 3
and 4 were incubated with a deletion in which the first 22 amino acids were deleted. The associated proteins were separated by SDS-PAGE
and visualized after transfer to nitrocellulose using an anti-myc antibody. Both were able to bind to GST-pRB, suggesting that the binding
site resides between amino acids 22 and 108. Other regions of the type I PIPkinase did not interact with pRB (data not shown).
(C) The three Type I PIPkinase isoforms,  (TI),  (TI), or  (TI), were expressed in Cos cells, and the lysates were used for affinity purification
with various GST fusion proteins. Lane 1: GST, lane 2: GST-pRB(379–917), lane 3: GST-pRB22, and lane 4: total Cos cell lysate. The panel
directly below shows a ponceau red staining of the various GST proteins, demonstrating that the their levels were equivalent.
(D) A total of 2 mg MEL cell lysates (lanes 1 and 2) was immunoprecipitated using either preimmune serum (lanes 1 and 3) or anti-Type I
PIPkinase antibodies (lane 2 and 4). The immunoprecipitations were separated by SDS-PAGE, Western blotted, and probed with an anti-pRB
antibody (Becton Dickinson 554136). In lanes 3 and 4, MEL cell lysate was replaced with lysis buffer, demonstrating that the band detected
by the pRB antibody is not present in the Type I anti-serum. To demonstrate that Type I PIPkinase was immunoprecipitated, 10% of the IP
was used to assess PIPkinase activity as described; preimmune: 87  11, antiPIPkinase: 9600  1000 (arbitrary units). The panel below shows
that approximately the same amount of immunoglobulin was present in all samples.
The data shown in these figures are representative of at least three independent experiments.
(compare lanes 1and 2 in Figure 4A). Although LTA will were isolated, and the levels of nuclear PtdIns(4,5)P2
were assessed using a mass assay (Figure 5). At 32C,bind to and repress other cell cycle proteins, such as
p53, we have not found any interaction between p53 there was a 4-fold decrease in the levels of nuclear
PtdIns(4,5)P2 as compared to the levels at 39C in cellsand Type I PIPkinases (data not shown). Considering
that pRB interacts both in vitro and in vivo with Type I expressing the temperature-sensitive mutant. No such
changes were seen in wild-type cells. We also saw noPIPkinases and that in vitro this interaction is abolished
by preincubation with LTA, we hypothesized that LTA changes in PtdIns(4,5)P2 levels at the plasma membrane
at the two different temperatures (data not shown), sug-overexpression may specifically inhibit the interaction
between pRB and Type I PIPkinase in vivo. To assess gesting that the regulation of Type I PIPkinase activity
by pRB occurs exclusively within the nucleus. Takenthe role of pRB interaction with Type I PIPkinase in vivo,
we isolated MEL cell lines overexpressing a tempera- together, these data suggest that, in vivo, pRB is able
to regulate the levels of nuclear PtdIns(4,5)P2 throughture-sensitive mutant of LTA. At 32C, this mutant is
stable in the nucleus and is able to repress pRB function, its ability to regulate the activity of Type I PIPkinases.
Although previous data have suggested a link be-while increasing the temperature to 39C leads to its
degradation (Figure 4B). tween cell cycle progression and activation of the nu-
clear inositide pathway [11], until now, no mechanismWild-type cells or cells expressing LTA (clone 13) were
incubated at either 32 or 39C overnight. The nuclei for the putative regulation of this pathway has been
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Figure 3. pRB Activates Type I PIPkinase In Vitro
Type I PIPkinase purified from Cos-7 cells was incubated with GST
or pRB(379–792). GST-pRB(379–792) was expressed in bacteria and
purified, and the GST portion was removed by cleavage with throm-
bin. As a control, the pRB or GST was boiled, and the precipitated
protein was removed by centrifugation. No Type I PIPkinase activity
was seen in any of the GST fusion proteins isolated from bacteria
(bacteria do not contain this activity), and, therefore, this is not the
reason for the increase in activity seen in the incubation with pRB.
Complexes were formed on ice for 1 hr and included PIPkinase,
pRB, or GST and lipid vesicles. The lipid products were isolated
Figure 4. Large T Antigen Blocks the Interaction between pRB andand separated by TLC, and the autoradiograms are shown. The
Type I PIPkinase and the Generation of a MEL Cell Line Expressingincorporation was quantified by phosphorimaging and is depicted
a Temperature-Sensitive Mutant of LTAgraphically below. The data shown are from one experiment, which
(A) Various amounts of GST-pRB(379–917) were either preincubatedis typical of three.
with lysis buffer (1) or with 200 l Cos cell lysate (2) for 2 hr. The
beads were washed two times with lysis buffer and incubated with
10 l Cos cell lysate expressing Type I PIPkinase. After an addi-suggested. The findings in this study show that Type I
tional 2 hr, the beads were washed, separated by SDS-PAGE, andPIPkinases, which are present in the nucleus and are
transferred to nitrocellulose. The blot was immunoprobed with an
the major route for the synthesis of nuclear PtdIns(4,5)P2, antibody against the Myc tag (to visualize the Type I PIPkinase)
are likely to be subject to regulation by pRB. Increased or with a monoclonal antibody against the LTA. The experiment
nuclear PtdIns(4,5)P2 synthesis, through the activation demonstrates that LTA binding to pRB is able to prevent the interac-
tion of pRB with the Type I PIPkinase.of Type I PIPkinases by pRB, may play a role in the
(B) MEL cells were transfected with a construct encoding a tempera-regulation of nuclear processes by recruiting nuclear
ture-sensitive mutant of LTA. Stable cells were selected using neo-lipid binding proteins such as the BAF complex [24].
mycin, and one such clone, C13, was incubated at the temperatures
The identification of other nuclear PtdIns(4,5)P2 binding shown for 2 days. Nuclei were isolated from these cells, and the
proteins should reveal further roles for pRB-mediated proteins were separated by SDS-PAGE, transferred to nitrocellulose,
regulation of nuclear PtdIns(4,5)P2 synthesis. and immunoprobed with an antibody against LTA. Subsequent ex-
periments were carried out with cells incubated at either 32C or at
Experimental Procedures 39C.
All chemical reagents were Analar grade and were purchased from
Sigma or from Boerhinger. Secondary antibodies were from DAKO
mM KCl, 2 mM EGTA) and resuspended in 50 l 10 mM Tris (pHand were used according to the manufacturer’s recommendations.
7.4), of which 10 l was removed and used to assess PIPkinaseWestern blots were visualized either using ECL (Amersham) or su-
activity, while the remainder was separated by SDS-PAGE, trans-persignal (Pierce).
ferred to nitrocellulose, and probed with a mouse anti-pRB antibody
(Becton Dickinson 554136).Cellular Lysates and Immunoprecipitations
Cos-7 cells (6-cm dish) were transfected using DEAE DextranRat brains were homogenized in isotonic buffer; cellular debris,
(final concentration of 500 g/ml). After 36 hr, cell lysates werebroken nuclei, and membranes were removed by centrifugation; and
prepared in 1 ml lysis buffer as described for the MEL cells, and 25the cytosols were adjusted to 5 mg/ml, frozen in liquid nitrogen,
l lysate was used in GST-affinity purifications.and stored at 	80C. MEL lysates were prepared using a detergent-
containing lysis buffer (50 mM Tris [pH 7.4], 50 mM KCl, 10 mM
MgCl2, 2 mM EGTA, NP40 1% [v/v]) and were stored as above. GST-Affinity Purification
GST fusion proteins (induced with 50 M IPTG) were prepared ac-MEL cell lysates (2 mg) were immunoprecipitated overnight using
a mix of anti-Type I PIPkinase antibodies (rabbit) [23]. The immuno- cording to the manufacturer’s instructions. For GST-affinity purifica-
tion, cell lysates were incubated with 2 g GST fusion protein for 1precipitates were washed with IP wash buffer (50 mM Tris [pH 7.4],
140 mM NaCl, 10 mM MgCl2, 0.1%[v/v] Tween 20) and then washed hr at 4C. They were washed three times in immunoprecipitation
(IP) wash buffer. They were finally resuspended in 40 l, and 5 lonce in PIPkinase buffer (50 mM Tris [pH 7.4], 20 mM MgCl2, 160
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PtdIns(4,5)P2 Measurements
A detailed procedure will be published elsewhere; breifly, however,
phosphorylated inositol-lipids isolated from nuclei were initially puri-
fied by neomycin chromatography as previously described [26]. The
samples were serially diluted in chloroform and then spotted onto
nitrocellulose membranes. After blocking nonspecific binding sites,
the membrane was incubated overnight with a GST-PH domain
(from PLC1, 0.1 g/ml in PBS-BSA [1%], Tween 20 [0.1%]) that
specifically recognizes PtdIns(4,5)P2. The blots were washed in the
above buffer without BSA and incubated with an anti-GST mono-
clonal antibody. After washing, the blots were incubated with an
anti-mouse antibody conjugated to horseradish peroxidase, and
visualization was carried out using supersignal (Pierce). Quantifica-
tion was achieved by direct visualization of the chemiluminescence
using a CCD camera (Alpha Innotech) and was compared to a stan-
dard curve generated by serial dilutions of known quantities of
PtdIns(4,5)P2.
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